RecruitingPhase 1NCT07365514

Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females

Blackcurrants Mitigate Postmenopausal Bone Loss Through Gut Microbiota-Bone Axis: A Randomized Clinical Trial Coupled With a Multi-Omics Approach to Inform Precision Nutrition


Sponsor

University of Connecticut

Enrollment

159 participants

Start Date

Jul 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate the effects of blackcurrant (BC) supplementation on changes in bone density and gut microbiome composition in postmenopausal females.


Eligibility

Sex: FEMALEMin Age: 45 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Blackcurrant (BC) extract, a drug called Blackcurrant (BC) extract, and others for people with gut microbiome, menopause, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 45 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBlackcurrant (BC) extract

Consume three capsules per day containing 784 mg of blackcurrant (BC) extract (261.33 mg BC and 130.67 mg placebo per capsule)

DRUGBlackcurrant (BC) extract

Consume three capsules containing 1,176 mg BC of extract (392 mg BC per capsule)

DRUGPlacebo

Consume three placebo capsules (392 mg placebo per capsule)


Locations(1)

University of Connecticut, Department of Nutritional Sciences

Storrs, Connecticut, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07365514


Related Trials